One-step assembly of polymeric demethylcantharate prodrug/Akt1 shRNA complexes for enhanced cancer therapy.
暂无分享,去创建一个
Lei Xing | S. Che | T. Jin | Mei Zhang | Peng-Fei Cui | Jian-Bin Qiao | Yu-Jing He | Hu‐Lin Jiang | Jia-Hui Gong | Jin-Yuan Lyu | Cheng-Qiong Luo | Jia-Liang Zhang
[1] Hui-zhen Jia,et al. Fabrication of dual responsive co-delivery system based on three-armed peptides for tumor therapy. , 2016, Biomaterials.
[2] Yi Yan Yang,et al. Co-delivery of drugs and plasmid DNA for cancer therapy. , 2016, Advanced drug delivery reviews.
[3] K. Nakashiro,et al. Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma. , 2015, International journal of oncology.
[4] U. Schubert,et al. Multifunctional poly(methacrylate) polyplex libraries: A platform for gene delivery inspired by nature. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[5] Li-xin Zhang,et al. Short hairpin RNA targeting AKT1 and PI3K/p85 suppresses the proliferation and self-renewal of lung cancer stem cells. , 2015, Molecular medicine reports.
[6] Xin-ping Li,et al. Norcantharidin enhances TIMP‑2 anti‑vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP‑2 and MT1‑MMP. , 2015, International journal of oncology.
[7] Lei Xing,et al. A novel potential biocompatible hyperbranched polyspermine for efficient lung cancer gene therapy. , 2015, International journal of pharmaceutics.
[8] Megan E Godsey,et al. Materials innovation for co-delivery of diverse therapeutic cargos. , 2013, RSC advances.
[9] Manman Guo,et al. Determination and pharmacokinetic study of the diacid metabolite of norcantharidin in beagle plasma by use of liquid chromatography–tandem mass spectrometry , 2013, Analytical and Bioanalytical Chemistry.
[10] Byungkuk Kim,et al. Acid-cleavable ketal containing poly(β-amino ester) for enhanced siRNA delivery. , 2013, International journal of pharmaceutics.
[11] Jun Li,et al. FGFR-targeted gene delivery mediated by supramolecular assembly between β-cyclodextrin-crosslinked PEI and redox-sensitive PEG. , 2013, Biomaterials.
[12] Bing Xu,et al. Disruption of the dynamics of microtubules and selective inhibition of glioblastoma cells by nanofibers of small hydrophobic molecules. , 2013, Angewandte Chemie.
[13] Toshinori Sato,et al. The effects of coating pDNA/chitosan complexes with chondroitin sulfate on physicochemical characteristics and cell transfection. , 2012, Biomaterials.
[14] D. Oupický,et al. Dual-function CXCR4 antagonist polyplexes to deliver gene therapy and inhibit cancer cell invasion. , 2012, Angewandte Chemie.
[15] Fei Wu,et al. Polyspermine imidazole-4,5-imine, a chemically dynamic and biologically responsive carrier system for intracellular delivery of siRNA. , 2012, Angewandte Chemie.
[16] Jianbin Tang,et al. Targeted acid-labile conjugates of norcantharidin for cancer chemotherapy , 2012 .
[17] A. Attia,et al. Advanced Materials for Co‐Delivery of Drugs and Genes in Cancer Therapy , 2012, Advanced healthcare materials.
[18] Shun-Fa Yang,et al. Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity , 2012, PloS one.
[19] Xian‐Zheng Zhang,et al. A strategy to improve serum-tolerant transfection activity of polycation vectors by surface hydroxylation. , 2011, Biomaterials.
[20] J. Gorman,et al. Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling. , 2011, Biomacromolecules.
[21] Jun Li,et al. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery. , 2011, Biomaterials.
[22] Kam W Leong,et al. Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. , 2011, ACS nano.
[23] Cheol-Heui Yun,et al. Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells. , 2009, International journal of pharmaceutics.
[24] Jianjun Cheng,et al. Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles. , 2009, Journal of the American Chemical Society.
[25] J. Nah,et al. Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[26] J. Nah,et al. Chitosan-graft-polyethylenimine as a gene carrier. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[27] Chen Dawei,et al. A less irritant norcantharidin lipid microspheres: formulation and drug distribution. , 2006, International journal of pharmaceutics.
[28] Timothy E. Long,et al. Michael addition reactions in macromolecular design for emerging technologies , 2006 .
[29] J. Nah,et al. Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[30] D. W. Pack,et al. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. , 2003, Bioconjugate chemistry.
[31] M. Westphal,et al. Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] P. Krammer,et al. Tumor Immunology , 2018, Medical Immunology.
[33] Robert Langer,et al. Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA , 2000 .
[34] Wei Wang,et al. The biocompatibility of fatty acid modified dextran-agmatine bioconjugate gene delivery vector. , 2012, Biomaterials.